GlassScriptPhysician profile
Michael G Ferguson
NPI 1215953575
$8,327.27
in general payments reported to CMS, 2019-2025
8 companies · $1,623 in 2025
The $1,623 reported for 2025 was more than what 90% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $863 · 2020: $257 · 2021: $1,478 · 2022: $2,801 · 2023: $785 · 2024: $520 · 2025: $1,623.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,822 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,822.13 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $105.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $5,869.33 | 2019-2025 | |
| Nobel Biocare USA | $1,074.55 | 2019-2023 | Nobelactive |
| Zimmer Biomet Holdings, INC. | $681.55 | 2019-2021 | |
| Zimvie INC. | $353.50 | 2022-2025 | |
| Geistlich Pharma, North America, INC. | $111.19 | 2019-2024 | Geistlich Bio-Gide |
| Dentsply Sirona INC | $101.87 | 2024 | Implant Dentistry |
| Biohorizons Implant Systems INC. | $81.40 | 2020-2024 | Biohorizons |
| Pacira Pharmaceuticals Incorporated | $53.88 | 2020-2024 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ferguson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.